# Weitai Medical Devices (Hangzhou) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/weitai-medical-devices-hangzhou-co

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.microtechmd.com
- Latest round: Series B (Dec 9, 2016)
- Investors on record: 5

## About

Based in Hangzhou, China, and founded in 2011 by Dore Mark, Weitai Medical Devices (Hangzhou) Co., Ltd., trading under the name MicroTech Medical, focuses on developing and providing medical monitoring devices for diabetes. In December 2020, Weitai Medical Devices (Hangzhou) Co., Ltd. raised CNY 575 million, co-led by Taikang Investment, Tencent Investment, and IDG Capital. As of November 2021, the company offers its products in 60 countries and has 100 staff.

MicroTech Medical's product line includes therapy products such as the Equil Patch Insulin Pump, which weighs around 23g with multiple alarms and has no wire around it. Diagnostic products such as the AiDEX Continuous Glucose Monitoring System (CGMS) which weighs around 5.5g and is a wearable device: multiple lines of Blood Glucose Monitoring Systems (BGMS), is a glucose testing equipment and POCT Analyzer System.

MicroTech Medical generated 38.85 million in the first four months of 2021.

MicroTech Medical is expected to be listed on the Hong Kong Stock Exchange.

## Funding rounds

- Series B, Dec 9, 2016 — Qiming Venture Partners, Haibang Venture, Juren Capital, CD Capital, Goldport Capital

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Haibang Venture — Series B
- Juren Capital (https://capitalatlas.ai/funds/juren-capital) — Series B
- CD Capital — Series B
- Goldport Capital (https://capitalatlas.ai/funds/goldport-capital) — Series B